9 results on '"Zou, Qiong"'
Search Results
2. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance
- Author
-
Yang, Zhulin, primary, Li, Daiqiang, additional, Liu, Ziru, additional, Miao, Xiongying, additional, Yang, Leping, additional, Zou, Qiong, additional, and Yuan, Yuan, additional
- Published
- 2017
- Full Text
- View/download PDF
3. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma
- Author
-
Yao, Hongliang, primary, Yang, Zhulin, additional, Liu, Ziru, additional, Miao, Xiongying, additional, Yang, Leping, additional, Li, Daiqiang, additional, Zou, Qiong, additional, and Yuan, Yuan, additional
- Published
- 2017
- Full Text
- View/download PDF
4. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma
- Author
-
Liu, Chun, primary, Yang, Zhulin, additional, Li, Daiqiang, additional, Liu, Ziru, additional, Miao, Xiongying, additional, Yang, Leping, additional, Zou, Qiong, additional, and Yuan, Yuan, additional
- Published
- 2015
- Full Text
- View/download PDF
5. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
- Author
-
Yang, Zhulin, Li, Daiqiang, Liu, Ziru, Miao, Xiongying, Yang, Leping, Zou, Qiong, and Yuan, Yuan
- Subjects
PANCREATIC diseases ,PROTEIN expression ,IMMUNOSTAINING ,IMMUNOHISTOCHEMISTRY ,LYMPH nodes ,GENE expression ,THERAPEUTICS - Abstract
This study investigated the KLF4 and BIRC7 protein expression in malignant and benign pancreatic tissues by immunohistochemical staining and the clinical and pathological significance of KLF4 and BIRC7 expression in PDAC. KLF4 expression was significantly lower, whereas BIRC7 expression was significantly higher in PDAC than that in peritumoral tissue, benign pancreatic lesions, and normal pancreatic tissue (P < 0.01). The percentage of positive BIRC7 and negative KLF4 expression was significantly lower in PDAC patients with well differentiated tumors, maximum tumor size < 3 cm, no lymph node metastasis, no invasion to the surrounding tissues and organs, and TNM stage I/II stage disease than in patients with poorly differentiated tumor, maximum tumor size > 5 cm, lymph node metastasis, invasion to surrounding tissues and organs, and TNM stage III/IV disease (P < 0.05 or P < 0.01). Kaplan-Meier survival analysis showed that the differentiation, maximum tumor size, TNM stage, lymph node metastasis, invasion, negative KLF4 expression, and positive BIRC7 expression were significantly associated with the short survival of patients with PDAC (P < 0.05 or P < 0.01). Cox multivariate analysis revealed that positive BIRC7 expression and negative KLF4 expression were independent poor prognosis factors in PDAC patients. In conclusions, positive BIRC7 expression and negative KLF4 expression are associated with the progression of PDAC and poor prognosis in patients with PDAC. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
6. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.
- Author
-
Yao, Hongliang, Yang, Zhulin, Liu, Ziru, Miao, Xiongying, Yang, Leping, Li, Daiqiang, Zou, Qiong, and Yuan, Yuan
- Subjects
PANCREATIC cancer ,CANCER chemotherapy ,IMMUNOHISTOCHEMISTRY ,METASTASIS ,CELL proliferation ,CANCER cells ,CANCER invasiveness - Abstract
OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with metastasis in most patients at diagnosis. The molecular mechanisms associated with its high malignancy have not been fully elucidated. This study investigated the clinicopathological significances of GPC3 and KRT19 expression in PDAC. METHODS: GPC3, KRT19, and CA19-9 protein expression were measured by immunohistochemistry. RESULTS: GPC3 and KRT19 protein levels were overexpressed in PDAC tumors compared to normal pancreatic tissues, benign pancreatic tissues, and peritumoral tissues (P< 0.01). The percentage of positive GPC3 and KRT19 expression were significantly higher in PDAC patients with larger tumor size, poorly differentiated tumor, lymph node metastasis, invasion, and TNM stage III/IV disease than in patients with small tumor size, well-differentiated tumor, no lymph node metastasis and invasion, as well as TNM stage I/II stage disease (P< 0.05 or P< 0.01). Benign pancreatic lesions with positive GPC3 and KRT19 protein expression exhibited dysplasia or intraepithelial neoplasia. Kaplan-Meier survival analysis showed that PDAC patients with positive GPC3 and KRT19 expression survived significantly shorter than patients with negative GPC3 and KRT19 expression (P < 0.05 or P< 0.001). Cox multivariate analysis revealed that positive GPC3 and KRT19 expression were independent poor prognosis factors in PDAC patients. CONCLUSIONS: GPC3 and KRT19 overexpression are associated with carcinogenesis, progression, and poor prognosis in patients with PDAC and a valuable biomarker for diagnosis of PDAC. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
7. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
- Author
-
Yuan Y, Yang Z, Miao X, Li D, Liu Z, and Zou Q
- Subjects
- ATP Binding Cassette Transporter, Subfamily G, Member 2, ATP-Binding Cassette Transporters genetics, Adaptor Proteins, Signal Transducing, Adenocarcinoma pathology, Aged, Biomarkers, Tumor genetics, Carcinoma, Pancreatic Ductal pathology, Female, Gene Expression Regulation, Neoplastic, Humans, Intracellular Signaling Peptides and Proteins genetics, Kaplan-Meier Estimate, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Proteins genetics, Neoplasm Staging, Prognosis, Proto-Oncogene Proteins genetics, ATP-Binding Cassette Transporters biosynthesis, Adenocarcinoma genetics, Biomarkers, Tumor biosynthesis, Carcinoma, Pancreatic Ductal genetics, Intracellular Signaling Peptides and Proteins biosynthesis, Neoplasm Proteins biosynthesis, Proto-Oncogene Proteins biosynthesis
- Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with intrinsic resistance to cytotoxic agents. The molecular mechanisms associated with high malignancy and resistance to chemotherapy and radiotherapy have not been fully elucidated. This study investigated the clinicopathological significances of frequently rearranged in advanced T-cell lymphomas-1 (FRAT1) and ATP-binding cassette subfamily G member 2 (ABCG2) expression in PDAC. FRAT1 and ABCG2 protein expression in 106 PDAC, 35 peritumoral tissues, 55 benign pancreatic tissues, and 13 normal pancreatic tissues was measured by immunohistochemistry. FRAT1 and ABCG2 protein was overexpressed in PDAC tumors compared to peritumoral tissues, benign pancreatic tissues, and normal pancreatic tissues (P < 0.01). The percentage of cases with positive FRAT1 and ABCG2 overexpression was significantly higher in PDAC patients with poor differentiation, lymph node metastasis, invasion, and TNM stage III/IV disease than in patients with well-differentiated tumor, no lymph node metastasis and invasion, and TNM stage I/II disease (P < 0.05 or P < 0.01). In pancreatic tissues with benign lesions, tissues with positive FRAT1 and ABCG2 protein expression exhibited dysplasia or intraepithelial neoplasia. Kaplan-Meier survival analysis showed that PDAC patients with positive FRAT1 and ABCG2 expression survived significantly shorter than patients with negative FRAT1 and ABCG2 expression (P < 0.05 or P < 0.001). Cox multivariate analysis revealed that positive FRAT1 and ABCG2 expression was an independent poor prognosis factor in PDAC patients. FRAT1 and ABCG2 overexpression is associated with carcinogenesis, progression, and poor prognosis in patients with PDAC.
- Published
- 2015
- Full Text
- View/download PDF
8. XRCC1 genetic polymorphism acts a potential biomarker for lung cancer.
- Author
-
Zhu DQ, Zou Q, Hu CH, Su JL, Zhou GH, and Liu P
- Subjects
- ATP Binding Cassette Transporter, Subfamily B genetics, Biomarkers, Tumor genetics, Gene Frequency, Genetic Predisposition to Disease, Genotype, Humans, X-ray Repair Cross Complementing Protein 1, DNA-Binding Proteins genetics, Lung Neoplasms genetics, Polymorphism, Single Nucleotide
- Abstract
Lung cancer is one of the most common but serious cancers in the world. Both the X-ray repair cross-complementing group 1 (XRCC1) gene and the human multidrug resistance 1 (MDR1) gene are important candidate genes influencing the susceptibility to various diseases, including lung cancer. This study aimed to assess the correlation of genetic polymorphisms in XRCC1 and MDR1 with the susceptibility to lung cancer. In this study, a total of 320 lung cancer patients and 346 cancer-free controls in Chinese population were enrolled in this study. Data about the clinical characteristics and related risk factors of lung cancer were collected by questionnaires. The single-nucleotide polymorphisms (SNPs) of XRCC1 and MDR1 genes were genotyped by created restriction site-polymerase chain reaction method. Our data showed that the risk for lung cancer increased significantly among the variant Arg194Trp (C > T, rs1799782) and Arg399Gln (G > A, rs25487) of XRCC1, but there are no significant differences in the allelic and genotypic frequencies of c.1564A > T and c.3073A > C of MDR1 between lung cancer patients and cancer-free controls. In conclusion, these preliminary results suggest that the C > T, rs1799782 and C > T, rs25487 of XRCC1 genetic variants might be used as molecular markers for detecting lung cancer susceptibility.
- Published
- 2015
- Full Text
- View/download PDF
9. ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
- Author
-
Li J, Yang ZL, Ren X, Zou Q, Yuan Y, Liang L, Chen M, and Chen S
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Enzyme Activation, Female, Gallbladder metabolism, Gallbladder pathology, Humans, Lymphatic Metastasis genetics, Male, Middle Aged, Neoplasm Invasiveness genetics, Peroxiredoxins genetics, Prognosis, Protein Serine-Threonine Kinases genetics, Adenocarcinoma enzymology, Adenocarcinoma genetics, Adenocarcinoma mortality, Adenocarcinoma pathology, Carcinoma, Adenosquamous enzymology, Carcinoma, Adenosquamous genetics, Carcinoma, Adenosquamous mortality, Carcinoma, Adenosquamous pathology, Carcinoma, Squamous Cell enzymology, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Gallbladder Neoplasms enzymology, Gallbladder Neoplasms genetics, Gallbladder Neoplasms mortality, Gallbladder Neoplasms pathology, Peroxiredoxins metabolism, Protein Serine-Threonine Kinases metabolism
- Abstract
Although the incidence of gallbladder cancers is low, they are highly aggressive tumors. Squamous cell/adenosquamous carcinoma (SC/ASC) is a rare subtype of gallbladder cancer. The clinical characteristics of SC/ASC have not been well documented, and no prognosis marker has been identified. In this study, we examined integrin-linked kinase (ILK) and peroxiredoxin-1 (PRDX1) expression in 46 SC/ASCs and 80 adenocarcinomas (ACs) by using immunohistochemistry and analyzed their correlations with clinicopathological characteristics. We demonstrated that positive ILK and PRDX1 expressions were significantly associated with large tumor size, high TNM stage, lymph node metastasis, and invasion of SC/ASC and AC. Univariate Kaplan-Meier analysis showed that positive ILK and PRDX1 expressions were closely associated with decreased overall survival in both SC/ASC (p < 0.001 and p = 0.005, respectively) and AC (p < 0.001) patients. Multivariate Cox regression analysis showed that positive ILK and PRDX1 expressions were an independent poor prognostic predictor in both SC/ASC and AC patients. We also revealed a similar significance of differentiation, tumor size, TNM stage, lymph node metastasis, invasion, and surgical curability with survival in SC/ASC and AC patients. Our study suggested that positive ILK and PRDX1 expressions are closely related to the progression and poor prognosis of gallbladder cancer.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.